中文

爱尔眼科 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-24
ItemAmountY/Y
Revenue¥6.40B+6.1%
Gross profit¥3.05B
Operating income¥1.60B
Net income¥1.31B+12.7%
Gross margin47.7%Net margin 20.6%
Revenue Q/Q+31.4%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥3.34B52.3%
R&D¥0.06B1.0%
SG&A¥1.32B20.7%
Tax & other¥0.28B4.4%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

同花顺东方财富智飞生物汇川技术光线传媒阳光电源中际旭创晶盛机电天孚通信三环集团芒果超媒昆仑万维

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies